Published in BMJ on June 17, 1989
Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst (2005) 2.93
The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy. Int J Cardiovasc Imaging (2009) 2.13
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer (1990) 1.73
Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense'). J R Soc Med (2010) 1.07
Contribution of randomised controlled trials to understanding and management of early breast cancer. BMJ (1999) 1.02
Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiat Oncol (2011) 1.02
Radiotherapy for ductal carcinoma in situ detected by screening. BMJ (1990) 1.00
Social class and weight as prognostic factors in early breast cancer. Br J Cancer (1997) 0.85
Radiotherapy, left-sided breast cancer, and ischaemic heart disease. Br Heart J (1993) 0.85
Successful radiation treatment of anaplastic thyroid carcinoma metastatic to the right cardiac atrium and ventricle in a pacemaker-dependent patient. Radiat Oncol (2011) 0.84
Breast cancer therapy-associated cardiovascular disease. Nat Rev Clin Oncol (2015) 0.83
Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. J Am Heart Assoc (2017) 0.76
Novel eradicative high-dose rate brachytherapy for internal mammary lymph node metastasis from breast cancer. World J Radiol (2012) 0.75
General surgery. Postgrad Med J (1990) 0.75
Adjuvant chemotherapy for early breast cancer. Br J Cancer (1990) 0.75
Radiation induced coronary heart disease. Br Heart J (1993) 0.75
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. J Clin Oncol (2017) 0.75
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol (1989) 2.18
Decreased survival related to irradiation postoperatively in early operable breast cancer. Lancet (1974) 1.79
Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol (1976) 1.28
The late effects of artificial menopause by X-radiation. Br J Radiol (1969) 0.98
The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy data. Br J Radiol (1984) 0.95
The role of radiotherapy following total mastectomy for patients with early breast cancer. World J Surg (1985) 0.94
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ (1990) 10.93
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed) (1986) 5.37
Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet (1976) 4.53
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet (1987) 3.84
Ethics of clinical research: lessons for the future. BMJ (1989) 3.77
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet (1994) 3.38
The curability of breast cancer. Lancet (1975) 3.37
Do we need informed consent? Lancet (1986) 3.02
Treatment of stage-II carcinoma of the female breast. Lancet (1966) 2.96
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet (1990) 2.77
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet (1998) 2.70
Breast cancer, desmoid tumours, and familial adenomatous polyposis--a unifying hypothesis. Lancet (1993) 2.69
Primary management of carcinoma of the breast. Lancet (1993) 2.59
Screening for breast cancer, time to think--and stop? Lancet (1995) 2.58
Natural history of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 2.52
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer (1982) 2.39
Structural organization and functional analysis of centromeric DNA in the fission yeast Schizosaccharomyces pombe. Mol Cell Biol (1988) 2.37
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Clinical syndromes of mastalgia. Lancet (1976) 2.35
Mass screening for cancer of the breast. Lancet (1968) 2.33
Is clinical breast examination an acceptable alternative to mammographic screening? BMJ (2000) 2.18
Oestrogen as a reticuloendothelial stimulant in patients with cancer. Br Med J (1971) 2.14
Can results from clinical trials be generalized? Nat Med (1995) 2.13
Time to abandon TNM staging of breast cancer? Lancet (1992) 2.05
The second specialty of general physicians. J R Coll Physicians Lond (1981) 2.04
Long-term survival of women with breast cancer. Lancet (1984) 1.86
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med (1990) 1.83
A 15-year follow-up study of patients treated for carcinoma of the breast. Br J Radiol (1968) 1.83
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
Treatment of stage-II carcinoma of the female breast. Lancet (1971) 1.76
A new biological framework for cancer research. Lancet (1996) 1.73
The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med (2008) 1.73
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Organization of clinical trial on national scale: management of early cancer of the breast. Br Med J (1972) 1.70
Reticulo-endothelial activity in humans with cancer. Br J Surg (1970) 1.69
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Do psychological studies upset patients? J R Soc Med (1987) 1.60
Should lymphadenectomy be discarded? I. Immunological considerations. J R Coll Surg Edinb (1973) 1.60
The effects of surgery on tumor growth: a century of investigations. Ann Oncol (2008) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J (1967) 1.58
Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58
Contralateral renal abnormalities in multicystic-dysplastic kidney disease. J Pediatr (1992) 1.57
Putting the risk of breast cancer in perspective. BMJ (1998) 1.56
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J (1977) 1.55
Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet Med (2002) 1.54
Influence of cholecystectomy on symptoms. Br J Surg (1991) 1.54
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
Tamoxifen and contralateral breast cancer. Lancet (1985) 1.53
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol (1997) 1.53
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol (1994) 1.53
False positive findings of mammography will have psychological consequences. BMJ (1996) 1.51
Does surgery disseminate or accelerate cancer? Lancet (1996) 1.50
Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) (1982) 1.49
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47
Addressing the psychological needs of the conservatively treated breast cancer patient: discussion paper. J R Soc Med (1987) 1.46
Rationalism versus irrationalism in the care of the sick: science versus the absurd. Med J Aust (1990) 1.46
Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ (1991) 1.46
Variations in gastric cancer mortality in South Wales. Clin Oncol (1979) 1.45
Comparison of 5-day, 1-day, and 2-day cyclical combination chemotherapy in advanced breast cancer. Lancet (1975) 1.45
Quality of life in cancer trials. Br Med J (Clin Res Ed) (1985) 1.44
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS (2008) 1.42
A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer (1980) 1.42
Cognition and immune function in HIV-1 infection. AIDS (1992) 1.41
Further study into obstructive jaundice and ischaemic renal damage. Br Med J (1969) 1.41
Mammographic accuracy and patient age: a study of 297 patients undergoing breast biopsy. Clin Radiol (1993) 1.40
Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol (2001) 1.39
Management of early carcinoma of the breast. Lancet (1972) 1.38
Multimodal therapy from stage-II breast cancer. Lancet (1978) 1.38
Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer. Lancet (1976) 1.38
Breast cancer screening for younger women is not an efficient use of resources. BMJ (1997) 1.38
Scientific empiricism and clinical medicine: a discussion paper. J R Soc Med (1981) 1.37
Replication of centromere II of Schizosaccharomyces pombe. Mol Cell Biol (1995) 1.35
Evidence for neutral transcellular NaCl transport and neutral basolateral chloride exit in the rabbit proximal convoluted tubule. J Clin Invest (1984) 1.32
Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest (1987) 1.32
High mutation rate and mutational bias at (TAA)n microsatellite loci in chickpea (Cicer arietinum L.). Mol Genet Genomics (2001) 1.32
Benign breast disease: the cost of the service and the cost to the patient. World J Surg (1990) 1.31
'Should a mammographic screening programme carry the warning: screening can damage your health!'? Br J Cancer (1999) 1.30
Structure and function of Schizosaccharomyces pombe centromeres. Cold Spring Harb Symp Quant Biol (1993) 1.30